Article Versions Notes

Gerotziafas GT, Van Dreden P, Fraser DD, Voiriot G, Patel MA, Daley M, Elabbadi A, Rousseau A, Prassas Y, Turpin M, et al. The COMPASS-COVID-19-ICU Study: Identification of Factors to Predict the Risk of Intubation and Mortality in Patients with Severe COVID-19. Hemato. 2022; 3(1):204-218. https://doi.org/10.3390/hemato3010017

Gerotziafas, Grigoris T., Patrick Van Dreden, Douglas D. Fraser, Guillaume Voiriot, Maitray A. Patel, Mark Daley, Alexandre Elabbadi, Aurélie Rousseau, Yannis Prassas, Matthieu Turpin, and et al. 2022. "The COMPASS-COVID-19-ICU Study: Identification of Factors to Predict the Risk of Intubation and Mortality in Patients with Severe COVID-19" Hemato 3, no. 1: 204-218. https://doi.org/10.3390/hemato3010017

Gerotziafas, G. T., Van Dreden, P., Fraser, D. D., Voiriot, G., Patel, M. A., Daley, M., Elabbadi, A., Rousseau, A., Prassas, Y., Turpin, M., Marchetti, M., Papageorgiou, L., Terpos, E., Dimopoulos, M. A., Falanga, A., Fareed, J., Fartoukh, M., & Elalamy, I. (2022). The COMPASS-COVID-19-ICU Study: Identification of Factors to Predict the Risk of Intubation and Mortality in Patients with Severe COVID-19. Hemato, 3(1), 204-218. https://doi.org/10.3390/hemato3010017